Who are Genomadix's investors?

Genomadix's investors include UCeed Funds.

Genomadix

2 known investors

Genomadix develops the Cube, a point-of-care PCR platform for real-time molecular testing in precision medicine and environmental applications. The company commercializes FDA-cleared genotyping tests and offers its open platform for partnerships with assay developers and clinical laboratories.

Biotech Digital Health Healthtech Medical Devices

Investors · 2

UCeed FundsCalgary · $25K – $300K

Also in the syndicate · 1

ICW Ventureslead

Funding

SEC filings, press & company announcements

Undisclosed amountseed roundJul 2022
ICW Ventures (lead)
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

GENOMADIX ANNOUNCES SECURING TWO YEARS OF FUNDINGnewswire.ca · Jul 2022

Canada's Spartan Bioscience Reemerges as Genomadix With Eye Toward Near-Patient COVID-19 Testing | GenomeWebgenomeweb.com · Sep 2021

Frequently asked questions

What does Genomadix do?: Genomadix develops the Cube, a point-of-care PCR platform for real-time molecular testing in precision medicine and environmental applications. The company commercializes FDA-cleared genotyping tests and offers its open platform for partnerships with assay developers and clinical laboratories.
Who are Genomadix's investors?: Genomadix's investors include UCeed Funds.